Hongxia Yan

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2021, Emerging microbes & infections.

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41

Yuxian He, Li Li, Yuanmei Zhu, 2022, Frontiers in Cellular and Infection Microbiology.

Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2020, Journal of Virology.

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals

L. Ren, Jianwei Wang, Yuxian He, 2020, Science Advances.